KILPEST INDIA LTD.
BSE: 532067
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 22.95-6.8% | 24.63+1.0% | 24.38-12.7% | 27.91+37.1% | 20.36-11.6% | 23.02-1.8% | 23.43-11.8% | 26.57 |
| Other Income | 5.30+306.9% | 1.30-71.9% | 4.63+18.4% | 3.91-9.3% | 4.31-12.1% | 4.91+63.0% | 3.01-12.2% | 3.43 |
| Total Income | 28.25+8.9% | 25.93-10.6% | 29.01-8.9% | 31.82+29.0% | 24.67-11.7% | 27.93+5.6% | 26.44-11.9% | 30.00 |
| EXPENSES | ||||||||
| Expenditure | 9.89-27.5% | 13.65+34.4% | 10.15-17.5% | 12.30+36.8% | 8.99-34.8% | 13.79+58.3% | 8.71-25.8% | 11.73 |
| Tax | 4.24-12.4% | 4.84+10.1% | 4.40-4.1% | 4.58+42.4% | 3.22-34.3% | 4.90+14.4% | 4.28+3.8% | 4.13 |
| PROFIT | ||||||||
| PBT | 18.35+49.4% | 12.29-34.8% | 18.86-3.4% | 19.52+24.5% | 15.68+10.9% | 14.14-20.2% | 17.73-2.9% | 18.27 |
| Net Profit | 14.11+89.5% | 7.45-48.5% | 14.46-3.2% | 14.94+19.9% | 12.46+34.8% | 9.24-31.3% | 13.45-4.9% | 14.14 |
| KEY METRICS | ||||||||
| OPM % | 57.90%+12.10pp | 45.80%-13.54pp | 59.34%+2.60pp | 56.74%-0.18pp | 56.92%+15.81pp | 41.11%-20.68pp | 61.79%+6.91pp | 54.88% |
| NPM % | 49.96%+21.25pp | 28.71%-21.14pp | 49.85%+2.90pp | 46.95%-3.56pp | 50.51%+17.41pp | 33.10%-17.76pp | 50.86%+3.72pp | 47.14% |
| EPS | 16.47+89.5% | 8.69-48.5% | 16.88-3.2% | 17.44+19.9% | 14.54+34.8% | 10.79-31.3% | 15.70-4.9% | 16.51 |
Corporate Events
Board Meeting3BBLACKBIO
202613Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board Meeting3BBLACKBIO
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board Meeting3BBLACKBIO
202413Nov
Board Meeting
Consideration And Approval Of Unaudited Standalone And Conso…
BSE Filing ↗ Board Meeting3BBLACKBIO
202429May
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗ Board Meeting3BBLACKBIO
20249Feb
Board Meeting
Consider and approve the Unaudited Standalone and Consolidat…
BSE Filing ↗